Steven J. Gray

Dystrophin Immunity in Duchenne's Muscular Dystrophy

Jerry R. Mendell, Katherine Campbell, Louise R. Rodino‐Klapac et al. · New England Journal of Medicine · 2010 · 655 citations · Full text

Medicine, Immunology, Molecular Genetics +15

Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates

Steven J. Gray, Valérie Matagne, Lavanya Bachaboina et al. · Molecular Therapy · 2011 · 504 citations · Full text

Pharmacy, Neurobiology, Neuroscience +17

Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary Vectors

Steven J. Gray, Stacey Beth Foti, Joel Schwartz et al. · Human Gene Therapy · 2011 · 417 citations

Life Sciences, Molecular Biology, Neuroscience +17

Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector

Dawn E. Bowles, Scott McPhee, Chengwen Li et al. · Molecular Therapy · 2011 · 392 citations · Full text

Pharmacy, Biotechnology, Immunology +16

Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates

Steven J. Gray, Sahana Nagabhushan Kalburgi, Thomas J. McCown et al. · Gene Therapy · 2013 · 372 citations

Pharmacy, Molecular Pharmaceutics, Neurobiology +14